- Tunlametinib Capsules approved with conditions for marketing by China NMPA2024-04-12
- Crovalimab Injection approved for marketing by China NMPA2024-04-08
- Tegileridine Fumarate Injection approved for marketing by China NMPA2024-04-03
- Innovative TCM Jiuwei cough syrup approved for marketing2024-02-27
- Ganagliflozin Proline Tablets approved for marketing by China NMPA2024-02-22
- Lecanemab Injection approved for marketing by China NMPA2024-01-31
- FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease2024-01-24
- Innovative TCM Ercha Shangqing Wan approved for marketing by China NMPA2024-01-17
- Atilotrelvir Tablets/Ritonavir Tablets (co-packaged) approved with conditions for marketin...2024-01-04
- Dimdazenil Capsules approved for marketing by China NMPA2024-01-04